Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
Leonard Kaps(Saarland University), Matthias Bros(Johannes Gutenberg University Mainz)
Cited by 12
Related Papers
DNA Vaccines—How Far From Clinical Use?
|International Journal of Molecular Sciences|2018|451
Interleukin-1 Beta—A Friend or Foe in Malignancies?
|International Journal of Molecular Sciences|2018|431
The Wnt/β-Catenin Pathway Attenuates Experimental Allergic Airway Disease
|The Journal of Immunology|2014|49
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB
|Journal of Experimental & Clinical Cancer Research|2014|12